openPR Logo
Press release

US Preventive Inhaler Market Overview by Recent Opportunities, Growth Size, Regional Analysis and Forecasts to 2025

05-19-2022 01:56 PM CET | Health & Medicine

Press release from: Orion Market Research

US preventive inhaler market is anticipated to grow at a substantial rate of 1.2% during the forecast period. The growth of the market of preventive inhalers in the US is mainly driven by factors that include the growing prevalence of chronic diseases such as asthma, diabetes, respiratory lung diseases and so on. Asthma is chronic inflammation of the lung airways that causes breathlessness and coughing. The number of people with asthma grows every year in the US. According to CDC, there are around 26 million asthma patients in the US, among which, nearly 18.9 million are adults and 7.1 million are children. Moreover, the prevalence of asthma in children is nearly 9.4% which is higher than that of adults accounting to around 7.7%, and higher in females nearly 9.2% than in males accounting to 7% of total asthma patients. This is one of the primary reasons for the high growth rate of the market within the country.

To Request a Sample of our Report on US Preventive Inhaler Market:

The US preventive inhaler market is segmented on the basis of device type, application, and end-user. On the basis of device, the market is sub-segmented into metered dosed inhaler and dry powdered inhaler. The dry powder inhaler is estimated to have the largest market share in the US preventive inhaler market due to providing an easy inhalation solution. Whereas, the market for metered dose inhaler is estimated to be the fastest-growing at a CAGR during the forecast period owing to innovations and collaborations by the companies for the development of metered dosed inhaler. Based on the application, the market has been classified into asthma and COPD diseases. In addition, based on the end-user, homecare and hospitals and clinics have been analyzed.

(Get 15% Discount on Buying this Report)

A full Report of US Preventive Inhaler Market is Available @

US Preventive Inhaler Market Segmentation

By Device Type

· Metered Dose Inhaler

· Dry Powder Inhaler

By Application

· Asthma

· Chronic Obstructive Pulmonary Disease (COPD)

By End-User

· Homecare

· Hospitals and Clinics

Company Profiles

· 3M Co.

· Acorda Therapeutics, Inc.

· Adamis Pharmaceuticals Corp.

· Adherium Ltd.

· Aradigm Corp.

· AstraZeneca PLC

· Boehringer Ingelheim International GmbH

· Drive Devilbiss Healthcare LLC

· GlaxoSmithKline PLC

· Koninklijke Philips N.V.

· Manta Devices LLC

· Novartis AG

· Omron Healthcare Inc.

· ResMed Corp.

· Pulmatrix Inc.

· Savara, Inc.

· Sunovion Pharmaceuticals

· Teva Pharmaceuticals Industries Ltd.

Reasons to buy from us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari


Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release US Preventive Inhaler Market Overview by Recent Opportunities, Growth Size, Regional Analysis and Forecasts to 2025 here

News-ID: 2630174 • Views: 94

More Releases from Orion Market Research

Pseudomonas Aeruginosa Pneumonia Drug Market Will Generate Record Revenue by 202 …
Pseudomonas is a type of bacteria which is found in the environment, such as in soil and water. Pseudomonas aeruginosa infections occur in people with weakened immune systems or in the hospital where there is a high risk of infection and is risky for patients with chronic lung diseases. The major factor driving the demand for pseudomonas aeruginosa pneumonia drug is the new product launches and drugs approval across the
Proteinase Activated Receptor Market: to Witness Growth Acceleration by 2028
Proteinase-activated receptors (PARs) are a subfamily of G protein-coupled receptors (GPCRs). These receptors have four members which include PAR1, PAR2, PAR3 and PAR4. These receptors play critical applications in hemostasis, thrombosis, embryonic development, wound healing, inflammation and cancer progression. The major factor driving the growth of the global proteinase activated receptor market is the rising prevalence of cancer across the globe. According to the National Cancer Institute (NCI), it was
Global Blood Warmer Market Competitive Landscape, Growth Factors, Revenue Analys …
The global blood warmer market is anticipated to grow at a significant CAGR of 8.9% during the forecast period. A blood warmer is a device used to warm blood, blood products, colloids, and other fluids which reduces the risk of hypothermia. To prevent the blood from the breakdown of the blood cells or hemolysis the refrigerated blood is warmed. The major factor driving the market growth is the increasing number
Global Motorhome Market Worldwide Industry Analysis, Future Demand and Forecast …
The global motorhome market is expected to grow at a CAGR of 8.5% during the forecast period. One of the factors that are fuelling the market growth is the speedily rising demand for comfortable accommodation and travel for large passenger groups. Travelling with family and friends during the time of holidays has been increasing in the past few years across the globe which has raised the demand for motorhome that

All 5 Releases

More Releases for Inhaler

Global Digital Dose Inhaler Market Insights, Forecast
Digital Dose Inhaler is a kind of medical instrument. Digital Dose Inhaler enable patients to the number of tracking has consumed doses. The global Digital Dose Inhaler market is valued at 1790 million US$ in 2018 and will reach 3540 million US$ by the end of 2025, growing at a CAGR of 8.9% during 2019-2025. The objectives of this study are to define, segment, and project the size of the
Dry Powder Inhaler Device Market: Competitive Dynamics & Global Outlook 2023
New report published by Market Research Report Store (MRRS) which offers insights on the global Dry Powder Inhaler Device market. A dry powder inhaler (DPI) is a device that delivers medication to the lungs in the form of a dry powder. DPIs are commonly used to treat respiratory diseases such as asthma, bronchitis, emphysema and COPD although DPIs (such as inhalable insulin Afrezza) have also been used in the treatment of
Dry Powder Inhaler Market Value Chain and Forecast 2017-2027
Globally there is an increasingly urgent need for effective treatment options for inhalation. Increasing prevalence of the chronic obstructive pulmonary diseases globally has led to the advent of a large number of inhalation devices. Dry powder inhalers refers to a device which helps in an effective delivery of medication to the lungs in the form of dry powder. The dry powder inhalers are portable and easy to carry which makes
Dry Powder Inhaler Device Market: Global Scenario 2022
This report studies the global Dry Powder Inhaler Device market, analyzes and researches the Dry Powder Inhaler Device development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like GlaxoSmithKline AstraZeneca Boehringer Ingelheim Chiesi Cipla 3M Hovione ….. Ask for sample copy @ Split by type, the market can be divided into Single dose Multi-dose Split by application, the market can be divided into Asthma COPD Market segment by Regions/Countries,
Respiratory Inhaler Devices Market Value CAGR to Grow at 4.3%
Future Market Insights (FMI) delivers key insights on the global respiratory inhaler devices market in its upcoming outlook titled, “Respiratory Inhaler Devices Market: Global Industry Analysis and Opportunity Assessment, 2015 – 2025”. In terms of value, the global respiratory inhaler devices market is projected to register a healthy CAGR of 4.3% during the forecast period due to various factors. This FMI report offers vital and detailed insights regarding these factors. The
Global Pressurized Metered Dose Inhaler Sales Market Report 2017
Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Pressurized Metered Dose Inhaler for these regions, from 2012 to 2022 (forecast), covering United States China Europe Japan Southeast Asia India Get sample report @ Global Pressurized Metered Dose Inhaler market competition by top manufacturers/players, with Pressurized Metered Dose Inhaler sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top